跳至主要内容
临床试验/CTRI/2021/02/031541
CTRI/2021/02/031541已完成未知

A study on the efficacy and adverse effects of Injection Remdesivir in moderate to severe SARS CoV-2 pneumonia in a tertiary care hospital in Kolkata.

nil0 个研究点目标入组 63 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Age =18 years at time of signing Informed Consent Form
  • 2.Laboratory (RT-PCR) confirmed COVID-19.
  • 3.Lung involvement confirmed with chest imaging
  • 4.Hospitalized with a SaO2/SPO2=94% on room air or Pa02/Fi02 ratio <300mgHg
  • 5.=12 days since illness onset
  • 6.Have given consent to participate in the study.

排除标准

  • 1.Severe liver disease (e.g. Child Pugh score = C, AST >5 times upper limit)
  • 2.Pregnant or breastfeeding, or positive pregnancy test in a pre dose examination
  • 3.Patients with known severe renal impairment (estimated glomerular filtration rate =30 mL/min/1.73 m2) or receiving continuous renal replacement therapy, hemodialysis, peritoneal dialysis
  • 4.Receipt of any experimental treatment for COVID-19 within the 30 days prior to the time of the screening evaluation.

研究者

发起方
nil

相似试验